Adjuvant capecitabine in resected biliary tract cancer: A real-world data from the BILCAP-Real study (ACABi multicenter cohort). // JHEP Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2589555926002399?dgcid=rss_sd_all
Adjuvant capecitabine in resected biliary tract cancer: A real-world data from the BILCAP-Real study (ACABi multicenter cohort). JHEP Reports. https://www.sciencedirect.com/science/article/pii/S2589555926002399?dgcid=rss_sd_all
“Adjuvant capecitabine in resected biliary tract cancer: A real-world data from the BILCAP-Real study (ACABi multicenter cohort).” JHEP Reports.
@article{article51117,
title = {Adjuvant capecitabine in resected biliary tract cancer: A real-world data from the BILCAP-Real study (ACABi multicenter cohort)},
journal = {JHEP Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2589555926002399?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...